Emami Q1 FY27 net profit drops 16% to ₹137 crore despite 15% revenue surge
Synopsis
Emami's Q1 FY27 results tell a split story: revenue surged nearly 15% but profit fell 16%, with EBITDA margins contracting 200 basis points to 21.7%. The gap between top-line growth and bottom-line delivery points to rising cost pressures — a warning sign for investors even as brand demand holds up across BoroPlus, Navratna, and Zandu.
Key Takeaways
Emami Limited reported a 16.38 per cent YoY fall in net profit to ₹137.3 crore in Q1 FY27 (April–June 2026).
Revenue from operations rose 14.9 per cent to ₹1,039.2 crore , up from ₹904.1 crore in Q1 FY26 .
EBITDA grew 5.5 per cent to ₹226.18 crore , but EBITDA margin contracted to 21.7 per cent from 23.7 per cent — a 200 basis point squeeze.
Emami shares fell 2.96 per cent to ₹394 on the NSE ; down 4.85 per cent over the past five sessions .
The company operates across 70+ countries via 4,000+ distributors and posted ₹3,780 crore turnover in FY26 .
Emami Limited, one of India's leading fast-moving consumer goods companies, reported a 16.38 per cent year-on-year decline in net profit for the first quarter of FY27 (April–June 2026), even as revenue grew at a robust double-digit pace. The Kolkata-based FMCG major posted a net profit of ₹137.3 crore for Q1 FY27, down from ₹164.2 crore in the same quarter last year, according to its stock exchange filing.
Revenue and Operating Performance
Despite the profit dip, Emami's top line showed strong momentum. Revenue from operations climbed 14.9 per cent year-on-year to ₹1,039.2 crore in the June quarter, up from ₹904.1 crore a year earlier — a sign that consumer demand for the company's portfolio of brands, including BoroPlus, Navratna, and Zandu, remained firm.
At the operating level, earnings before interest, taxes, depreciation and amortisation (EBITDA) rose 5.5 per cent to ₹226.18 crore, compared with ₹214.29 crore in Q1 FY26. However, EBITDA growth lagged revenue growth, a divergence that squeezed margins.
Margin Pressure Takes Centre Stage
The headline concern for investors is the compression in operating margins. Emami's EBITDA margin narrowed to 21.7 per cent in Q1 FY27, down from 23.7 per cent in the corresponding quarter of the previous financial year — a contraction of 200 basis points. This suggests that cost pressures, likely in raw materials or advertising and promotional spends, outpaced the benefit of higher revenues during the quarter.
Notably, this margin squeeze is a pattern seen across several FMCG players this earnings season, as input costs and competitive intensity have risen simultaneously. For Emami, which operates in the personal care and healthcare segments, brand investment tends to be a significant cost lever.
About Emami: Scale and Reach
Founded in 1974 by R.S. Agarwal and R.C. Goenka, Emami has built a diversified portfolio spanning personal care and healthcare through brands such as BoroPlus, Navratna, Zandu, Kesh King, Dermicool, and The Man Company. Headquartered in Kolkata, the company operates through a network of over 4,000 distributors and has a presence in more than 70 countries. Emami reported a total turnover of ₹3,780 crore in FY26.
Stock Market Reaction
The market responded negatively to the results. Emami shares were trading at ₹394 on the National Stock Exchange (NSE), down 2.96 per cent or ₹12 on the day. Over the preceding five trading sessions, the stock had shed 4.85 per cent, or ₹20.10, reflecting growing investor caution ahead of and following the quarterly disclosure.
With revenue momentum intact but margins under pressure, the key question for Emami's next quarter is whether the company can translate its top-line strength into improved profitability — or whether cost headwinds will continue to erode the bottom line.
Point of View
Squeezed bottom line — has been building across the FMCG sector for two quarters, and Emami's diversified but premium-leaning portfolio makes it more vulnerable to trade-down if consumer sentiment softens. The stock's 5% slide over five sessions signals that the market is already pricing in that risk.
NationPress
5 Aug 2026
Frequently Asked Questions
What were Emami's Q1 FY27 results?
Emami reported a net profit of ₹137.3 crore for Q1 FY27 (April–June 2026), a decline of 16.38 per cent compared with ₹164.2 crore in Q1 FY26. Revenue from operations, however, rose 14.9 per cent to ₹1,039.2 crore during the same period.
Why did Emami's net profit fall despite higher revenue?
The profit decline occurred even as revenue grew because operating margins compressed significantly — EBITDA margin fell to 21.7 per cent from 23.7 per cent a year earlier, a contraction of 200 basis points. This suggests cost pressures outpaced the gains from higher sales during the quarter.
How did Emami shares react to the Q1 FY27 results?
Emami shares fell 2.96 per cent to ₹394 on the NSE on the day the results were reported. Over the five preceding trading sessions, the stock had already declined 4.85 per cent, or ₹20.10.
Which brands does Emami own?
Emami's portfolio includes well-known brands such as BoroPlus, Navratna, Zandu, Kesh King, Dermicool, and The Man Company, spanning personal care and healthcare segments. The company was founded in 1974 and is headquartered in Kolkata.
What was Emami's full-year FY26 turnover?
Emami reported a total turnover of ₹3,780 crore in FY26. The company distributes its products through a network of over 4,000 distributors and has a presence in more than 70 countries.
